Free Trial

National Vision (EYE) Competitors

National Vision logo
$21.48 +0.47 (+2.21%)
As of 10:54 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

EYE vs. STVN, GKOS, NARI, IRTC, TMDX, BLCO, INSP, SLNO, PRCT, and NVST

Should you be buying National Vision stock or one of its competitors? The main competitors of National Vision include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), iRhythm Technologies (IRTC), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Soleno Therapeutics (SLNO), PROCEPT BioRobotics (PRCT), and Envista (NVST). These companies are all part of the "medical equipment" industry.

National Vision vs.

Stevanato Group (NYSE:STVN) and National Vision (NASDAQ:EYE) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership, community ranking, media sentiment and profitability.

Stevanato Group has higher earnings, but lower revenue than National Vision. National Vision is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group$1.12B6.62$157.62M$0.5148.20
National Vision$1.85B0.90-$65.90M-$0.33-63.70

In the previous week, Stevanato Group and Stevanato Group both had 6 articles in the media. National Vision's average media sentiment score of 1.11 beat Stevanato Group's score of 1.03 indicating that National Vision is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
National Vision
3 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

National Vision received 227 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 64.50% of users gave National Vision an outperform vote while only 63.27% of users gave Stevanato Group an outperform vote.

CompanyUnderperformOutperform
Stevanato GroupOutperform Votes
31
63.27%
Underperform Votes
18
36.73%
National VisionOutperform Votes
258
64.50%
Underperform Votes
142
35.50%

Stevanato Group has a beta of 0.53, suggesting that its stock price is 47% less volatile than the S&P 500. Comparatively, National Vision has a beta of 1.24, suggesting that its stock price is 24% more volatile than the S&P 500.

National Vision has a consensus target price of $17.75, indicating a potential downside of 15.56%. Given National Vision's higher probable upside, analysts plainly believe National Vision is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.86
National Vision
0 Sell rating(s)
5 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.44

Stevanato Group has a net margin of 10.47% compared to National Vision's net margin of -0.81%. Stevanato Group's return on equity of 9.86% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group10.47% 9.86% 5.79%
National Vision -0.81%3.52%1.39%

Summary

Stevanato Group beats National Vision on 9 of the 15 factors compared between the two stocks.

Get National Vision News Delivered to You Automatically

Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EYE vs. The Competition

MetricNational VisionOphthalmic goods IndustryStaples SectorNASDAQ Exchange
Market Cap$1.66B$10.61B$17.49B$8.67B
Dividend YieldN/A0.96%3.06%4.19%
P/E Ratio-105.0933.2316.3920.17
Price / Sales0.903.104.25161.94
Price / Cash7.0314.5316.3934.64
Price / Book1.982.666.144.72
Net Income-$65.90M$224.27M$737.42M$247.80M
7 Day Performance0.62%3.35%0.33%2.76%
1 Month Performance22.42%13.23%1.64%9.71%
1 Year Performance46.38%-17.68%2.10%14.51%

National Vision Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EYE
National Vision
3.2407 of 5 stars
$21.49
+2.2%
$17.75
-17.4%
+46.7%$1.69B$1.85B-106.9714,000Positive News
STVN
Stevanato Group
1.5526 of 5 stars
€22.01
-0.9%
N/A+32.9%$6.67B$1.12B46.834,650Positive News
GKOS
Glaukos
4.5725 of 5 stars
$94.89
+0.6%
$134.67
+41.9%
-15.2%$5.42B$404.52M-33.06780
NARI
Inari Medical
0.2473 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800News Coverage
IRTC
iRhythm Technologies
1.0797 of 5 stars
$140.65
+0.1%
$133.73
-4.9%
+56.1%$4.49B$618.59M-38.641,790
TMDX
TransMedics Group
1.5828 of 5 stars
$123.94
-2.5%
$126.70
+2.2%
-2.6%$4.19B$488.23M131.85210
BLCO
Bausch + Lomb
3.6768 of 5 stars
$11.46
-0.1%
$15.50
+35.3%
-16.2%$4.05B$4.83B-12.5912,500Analyst Forecast
INSP
Inspire Medical Systems
4.8043 of 5 stars
$133.66
-3.3%
$211.91
+58.5%
-15.2%$3.94B$840.11M77.26760Positive News
SLNO
Soleno Therapeutics
4.8894 of 5 stars
$75.66
+3.1%
$106.78
+41.1%
+69.6%$3.81BN/A-22.7930Positive News
Analyst Revision
PRCT
PROCEPT BioRobotics
1.8166 of 5 stars
$57.94
-0.1%
$90.00
+55.3%
-6.5%$3.21B$249.12M-29.71430Gap Up
NVST
Envista
3.7951 of 5 stars
$18.09
-1.0%
$20.23
+11.8%
+5.5%$3.07B$2.50B-2.7912,700Positive News

Related Companies and Tools


This page (NASDAQ:EYE) was last updated on 6/11/2025 by MarketBeat.com Staff
From Our Partners